A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria.

Cell Host & Microbe
Rachel D HoodJoseph D Mougous

Abstract

The functional spectrum of a secretion system is defined by its substrates. Here we analyzed the secretomes of Pseudomonas aeruginosa mutants altered in regulation of the Hcp Secretion Island-I-encoded type VI secretion system (H1-T6SS). We identified three substrates of this system, proteins Tse1-3 (type six exported 1-3), which are coregulated with the secretory apparatus and secreted under tight posttranslational control. The Tse2 protein was found to be the toxin component of a toxin-immunity system and to arrest the growth of prokaryotic and eukaryotic cells when expressed intracellularly. In contrast, secreted Tse2 had no effect on eukaryotic cells; however, it provided a major growth advantage for P. aeruginosa strains, relative to those lacking immunity, in a manner dependent on cell contact and the H1-T6SS. This demonstration that the T6SS targets a toxin to bacteria helps reconcile the structural and evolutionary relationship between the T6SS and the bacteriophage tail and spike.

References

Jul 20, 2002·Biochemical and Biophysical Research Communications·Soumita DasKeya Chaudhuri
Jul 27, 2002·Annual Review of Microbiology·Margaret A Riley, John E Wertz
Mar 5, 2003·Current Opinion in Microbiology·Drusilla L Burns
Jul 12, 2003·FEMS Microbiology Letters·T D LawleyL S Frost
Nov 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Michael A JacobsColin Manoil
Jan 13, 2004·Proceedings of the National Academy of Sciences of the United States of America·Zhao-Qing Luo, Ralph R Isberg
Feb 3, 2005·Molecular Microbiology·Jodi L Enos-BerlageLinda L McCarter
May 3, 2005·Nature Reviews. Microbiology·Kenn GerdesAnders Løbner-Olesen
May 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Arne RietschJohn J Mekalanos
Aug 20, 2005·Science·Stephanie K AokiDavid A Low
Sep 13, 2005·Annual Review of Microbiology·Peter J ChristieEric Cascales
Dec 24, 2005·Proceedings of the National Academy of Sciences of the United States of America·Isabelle VentreAlain Filloux
May 24, 2006·Proceedings of the National Academy of Sciences of the United States of America·Dao Nguyen, Pradeep K Singh
Jun 10, 2006·Science·Joseph D MougousJohn J Mekalanos
Jun 17, 2006·Current Opinion in Microbiology·Matthew J Wargo, Deborah A Hogan
Sep 15, 2006·The New England Journal of Medicine·Timothy L Yahr
Dec 19, 2006·Proceedings of the National Academy of Sciences of the United States of America·Lucas R HoffmanSamuel I Miller
Apr 21, 2007·Nature Protocols·Olof EmanuelssonHenrik Nielsen
Jun 15, 2007·Nature Cell Biology·Joseph D MougousJohn J Mekalanos
Jul 31, 2007·Future Microbiology·Christopher D SibleyMichael G Surette
Sep 18, 2007·Journal of Bacteriology·Kelli L PalmerMarvin Whiteley
Sep 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Stefan PukatzkiJohn J Mekalanos
Oct 9, 2007·Nature Reviews. Microbiology·Abdallah M AbdallahWilbert Bitter
Nov 6, 2007·Current Opinion in Microbiology·Cynthia RyderDaniel J Wozniak
Nov 8, 2007·Molecular Microbiology·Jun Zheng, Ka Yin Leung
Feb 22, 2008·Current Opinion in Microbiology·Lewis Eh BingleMark J Pallen
Mar 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Edward R BallisterJoseph D Mougous

❮ Previous
Next ❯

Citations

May 25, 2011·Applied Microbiology and Biotechnology·Elisabeth Sonnleitner, Dieter Haas
Apr 2, 2013·Research in Microbiology·Sarah J Coulthurst
Mar 12, 2013·Trends in Microbiology·Zachary C RuheChristopher S Hayes
Jul 22, 2011·Nature·Alistair B RussellJoseph D Mougous
Oct 27, 2010·Proceedings of the National Academy of Sciences of the United States of America·Dana L MacIntyreStefan Pukatzki
Nov 15, 2012·Proceedings of the National Academy of Sciences of the United States of America·Michele LeRouxJoseph D Mougous
Jan 31, 2013·Proceedings of the National Academy of Sciences of the United States of America·Tao G DongJohn J Mekalanos
Apr 11, 2013·Proceedings of the National Academy of Sciences of the United States of America·Sanna KoskiniemiChristopher S Hayes
Feb 18, 2011·The Journal of Biological Chemistry·Abderrahman HachaniAlain Filloux
Aug 18, 2012·The Journal of Biological Chemistry·Eric DurandChristian Cambillau
Jul 12, 2013·Molecular & Cellular Proteomics : MCP·Maximilian J FritschSarah J Coulthurst
Nov 13, 2012·Nucleic Acids Research·Deepak BalasubramanianKalai Mathee
Mar 3, 2011·Molecular Plant-microbe Interactions : MPMI·Angela R Records
Mar 14, 2012·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Eric Cascales, Christian Cambillau
Nov 29, 2011·Acta Crystallographica. Section D, Biological Crystallography·Vincenzo A RaoWilliam N Hunter
Jun 15, 2011·Infection and Immunity·Yahua ChenYunn-Hwen Gan
Nov 16, 2011·Infection and Immunity·Takahiko IshikawaSun Nyunt Wai
Mar 8, 2011·Journal of Bacteriology·Christophe S BernardEric Cascales
May 18, 2010·Journal of Bacteriology·Angela R Records, Dennis C Gross
Jun 1, 2010·Journal of Bacteriology·Christophe S BernardEric Cascales
Sep 6, 2011·Journal of Bacteriology·Sarah L MurdochSarah J Coulthurst
Sep 10, 2013·Canadian Journal of Microbiology·Lauren M Petersen, Louis S Tisa
Jun 27, 2013·BMC Genomics·Oliver Ki BezuidtBurkhard Tümmler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Dana L MacIntyreStefan Pukatzki
Proceedings of the National Academy of Sciences of the United States of America
Stefan PukatzkiJohn J Mekalanos
© 2021 Meta ULC. All rights reserved